Ageing with HIV is now a global public health reality, especially in sub-Saharan Africa, and the response must evolve to reflect that.
Articles on World AIDS Day 2025
Displaying all articles
The US cuts in research funding are devastating to the fight against HIV/Aids. It’s going to be very hard to recover.
Pepfar, a global initiative to fight HIV/Aids, has saved millions of lives since its launch in 2003. Now its future is uncertain.
Aids was first identified 40 years ago: these are the game changers that have revolutionised treatment – and the obstacles that remain.
Each life lost to Aids is a life too many. As donor funds dry up, Africa needs new ways to fight this epidemic.
A breakthrough drug is a significant step forward in the fight against HIV. But without changes in behaviour, infection rates won’t come down.
Top contributors
-
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
-
Visiting Researcher at Sydney Brenner Institute for Molecular Bioscience, University of the Witwatersrand
-
Law and policy analyst, Georgetown University
-
Infectious disease and public health expert, University of Verona
-
University Professor; Founding Linda D. & Timothy J. O’Neill Professor of Global Health Law, Georgetown University
-
Research Manager at MRC/Wits Agincourt Research Unit, University of the Witwatersrand
-
Dr Yogan Pillay is the director for HIV and TB delivery at the Bill and Melinda Gates and He is currently extraordinary professor in the Department of Preventive Medicine, University of Pretoria
-
Distinguished Professor, Infectious Disease and Oncology Research Institute, Faculty of Heath Sciences, University of the Witwatersrand, Executive Director Perinatal HIV Research Unit, Chief Scientific Officer, South African Medical Research Council
-
Researcher, Georgetown University
-
Chief Scientific Officer, Desmond Tutu Health Foundation and Senior Researcher, University of the Witwatersrand